Literature DB >> 11877329

Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice.

André Klein1, Vanessa Pinho, Ana Letícia Alessandrini, Takao Shimizu, Satoshi Ishii, Mauro M Teixeira.   

Abstract

1. The activation of eosinophils via G-protein-coupled seven transmembrane receptors play a necessary role in the recruitment of these cells into tissue. The present study investigates a role for PAF in driving eotaxin production and eosinophil recruitment in an allergic pleurisy model in mice. 2. The intrapleural injection of increasing doses of PAF (10(-11) to 10(-9) moles per cavity) induced a dose- and PAF receptor-dependent recruitment of eosinophils 48 h after stimulation. 3. Intrapleural injection of PAF induced the rapid (within 1 h) release of eotaxin into the pleural cavity of mice and an anti-eotaxin antibody effectively inhibited PAF-induced recruitment of eosinophils. 4. Eosinophil recruitment in the allergic pleurisy was markedly inhibited by the PAF receptor antagonist UK-74,505 (modipafant, 1 mg kg(-1)). Moreover, recruitment of eosinophils in sensitized and challenged PAF receptor-deficient animals was lower than that observed in wild-type animals. 5. Blockade of PAF receptors with UK-74,505 suppressed by 85% the release of eotaxin in the allergic pleurisy. 6. Finally, the injection of a sub-threshold dose of PAF and eotaxin cooperated to induce eosinophil recruitment in vivo. 7. In conclusion, the production of PAF in an allergic reaction could function in multiple ways to facilitate the recruitment of eosinophils -- by facilitating eotaxin release and by cooperating with eotaxin to induce greater recruitment of eosinophils.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877329      PMCID: PMC1573234          DOI: 10.1038/sj.bjp.0704570

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

Review 1.  Chemokines and asthma: redundancy of function or a coordinated effort?

Authors:  N W Lukacs; S H Oliveira; C M Hogaboam
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Blockade of PAF receptors controls interleukin-8 production by regulating the activation of neutrophil CD11/CD18.

Authors:  B T Au; M M Teixeira; P D Collins; T J Williams
Journal:  Eur J Pharmacol       Date:  2001-08-03       Impact factor: 4.432

3.  Release of platelet-activating factor is important for the respiratory burst induced in human eosinophils by opsonized particles.

Authors:  A T Tool; L Koenderman; P T Kok; M Blom; D Roos; A J Verhoeven
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

4.  UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo.

Authors:  V A Alabaster; R F Keir; M J Parry; R N de Souza
Journal:  Agents Actions Suppl       Date:  1991

5.  Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo.

Authors:  S Fukuyama; H Inoue; H Aizawa; M Oike; M Kitaura; O Yoshie; N Hara
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

6.  Stem cell factor-induced leukotriene B4 production cooperates with eotaxin to mediate the recruitment of eosinophils during allergic pleurisy in mice.

Authors:  A Klein; A Talvani; P M Silva; M A Martins; T N Wells; A Proudfoot; N W Luckacs; M M Teixeira
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

7.  Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man.

Authors:  E Henocq; B B Vargaftig
Journal:  Lancet       Date:  1986-06-14       Impact factor: 79.321

8.  Generation of an eosinophilotactic activity in the pleural cavity of platelet-activating factor-injected rats.

Authors:  P M e Silva; M A Martins; H C Faria Neto; R S Cordeiro; B B Vargaftig
Journal:  J Pharmacol Exp Ther       Date:  1991-06       Impact factor: 4.030

9.  Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea-pig skin.

Authors:  M M Teixeira; S Reynia; M Robinson; A Shock; T J Williams; F M Williams; A G Rossi; P G Hellewell
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

10.  Cooperation between Fc gamma receptor II and complement receptor type 3 during activation of platelet-activating factor release by cytokine-primed human eosinophils.

Authors:  T van der Bruggen; P T Kok; J A Raaijmakers; J W Lammers; L Koenderman
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

View more
  4 in total

1.  Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils.

Authors:  Rossana C N Melo; Sandra A C Perez; Lisa A Spencer; Ann M Dvorak; Peter F Weller
Journal:  Traffic       Date:  2005-10       Impact factor: 6.215

2.  Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment.

Authors:  Danielle G Souza; Vanessa Pinho; Adriana C Soares; Takao Shimizu; Satoshi Ishii; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

3.  Platelet-activating factor receptor deficiency delays elimination of adult worms but reduces fecundity in Strongyloides venezuelensis-infected mice.

Authors:  Deborah Negrão-Corrêa; Danielle G Souza; Vanessa Pinho; Michele M Barsante; Adriano L S Souza; Mauro M Teixeira
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

4.  Mechanisms underlying the inhibitory effects of tachykinin receptor antagonists on eosinophil recruitment in an allergic pleurisy model in mice.

Authors:  Ana Leticia Alessandri; Vanessa Pinho; Danielle G Souza; Maria Salete de A Castro; Andre Klein; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2003-11       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.